BFG
Bleakley Financial Group Portfolio holdings
AUM
$3.94B
This Quarter Return
+5.69%
1 Year Return
+21.4%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.2B
AUM Growth
+$3.2B
(+7%)
Cap. Flow
+$70.9M
Cap. Flow
% of AUM
2.21%
Top 10 Holdings %
Top 10 Hldgs %
28.66%
Holding
997
New
87
Increased
511
Reduced
304
Closed
71
Top Buys
| 1 |
Vanguard Mid-Cap ETF
VO
|
$6.94M |
| 2 |
HCA Healthcare
HCA
|
$6.55M |
| 3 |
Vanguard Large-Cap ETF
VV
|
$6.26M |
| 4 |
Vanguard Total World Stock ETF
VT
|
$4.64M |
| 5 |
Procter & Gamble
PG
|
$3.72M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$9.4M |
| 2 |
Apple
AAPL
|
$6.86M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
$6.53M |
| 4 |
Agilent Technologies
A
|
$6.47M |
| 5 |
Abbott
ABT
|
$5.94M |
Sector Composition
| 1 | Technology | 11.85% |
| 2 | Healthcare | 10.44% |
| 3 | Financials | 5.01% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Communication Services | 3.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Outdoor Holding Company Common Stock
POWW
$167M
| $54.8K | ﹤0.01% | 25,723 -129 | -0.5% | -$275 |
|
902
Precigen
PGEN
$1.34B
| $49.7K | ﹤0.01% | 43,191 +4,121 | +11% | +$4.74K |
|
903
Olaplex Holdings
OLPX
$954M
| $43.9K | ﹤0.01% | +11,796 | New | +$43.9K |
|
904
ADMA Biologics
ADMA
$4.12B
| $40.7K | ﹤0.01% | 11,022 -340 | -3% | -$1.26K |
|
|
CTEV
905
Claritev Corporation
CTEV
$1.14B
| $40.1K | ﹤0.01% | 19,004 +1,075 | +6% | +$2.27K |
|
906
Compass
COMP
$4.77B
| $37.4K | ﹤0.01% | 10,672 -1,572 | -13% | -$5.5K |
|
907
TrueCar
TRUE
$195M
| $36.4K | ﹤0.01% | 16,126 -2,481 | -13% | -$5.61K |
|
908
NextNav
NN
$2.37B
| $36K | ﹤0.01% | 12,261 | – | – |
|
909
Ginkgo Bioworks
DNA
$750M
| $30.6K | ﹤0.01% | +16,436 | New | +$30.6K |
|
910
Karyopharm Therapeutics
KPTI
$61.7M
| $28.6K | ﹤0.01% | +15,966 | New | +$28.6K |
|
|
CANO
911
DELISTED
Cano Health, Inc.
CANO
| $25.6K | ﹤0.01% | 18,394 -5,944 | -24% | -$8.26K |
|
912
Gannett
GCI
$603M
| $24.7K | ﹤0.01% | +10,963 | New | +$24.7K |
|
913
Lumen
LUMN
$5.1B
| $24.4K | ﹤0.01% | 10,807 -3,928 | -27% | -$8.88K |
|
|
WE
914
DELISTED
WeWork Inc.
WE
| $22.2K | ﹤0.01% | +87,041 | New | +$22.2K |
|
915
Nkarta
NKTX
$151M
| $22.2K | ﹤0.01% | +10,127 | New | +$22.2K |
|
916
Matinas BioPharma
MTNB
$10.1M
| $21.6K | ﹤0.01% | 60,016 | – | – |
|
|
CRGE
917
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $20.1K | ﹤0.01% | 20,555 -1,569 | -7% | -$1.54K |
|
918
Crexendo
CXDO
$191M
| $19.4K | ﹤0.01% | 11,000 | – | – |
|
919
ESS Tech
GWH
$20.8M
| $15.9K | ﹤0.01% | +10,817 | New | +$15.9K |
|
|
NYMX
920
DELISTED
Nymox Pharmaceutical Corp
NYMX
| $15.2K | ﹤0.01% | 80,000 | – | – |
|
|
MMAT
921
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $11K | ﹤0.01% | 51,200 | – | – |
|
922
Clover Health Investments
CLOV
$1.34B
| $9.95K | ﹤0.01% | +11,089 | New | +$9.95K |
|
923
Comscore
SCOR
$33.4M
| $8.91K | ﹤0.01% | 11,000 | – | – |
|
|
ID
924
DELISTED
PARTS iD, Inc.
ID
| $8.34K | ﹤0.01% | 20,000 | – | – |
|
|
FXLV
925
DELISTED
F45 Training Holdings Inc.
FXLV
| $7.5K | ﹤0.01% | +15,000 | New | +$7.5K |
|